Contrast-Enhanced Echocardiography Application in Patients Supported by Extracorporeal Membrane Oxygenation (ECMO): A Narrative Review

J Cardiothorac Vasc Anesth. 2022 Jul;36(7):2080-2089. doi: 10.1053/j.jvca.2021.04.031. Epub 2021 May 2.

Abstract

Extracorporeal membrane oxygenation (ECMO) is a lifesaving intervention increasingly used to support patients with severe respiratory and cardiac dysfunction. Echocardiography is an important tool, aiding implantation and monitoring during ECMO therapy, but often its use is limited by poor acoustic windows. This limitation may be overcome by the use of echocardiography contrast agents to improve diagnostic yield and reduce the need for other imaging modalities that may require patient transfer, involve ionizing radiation and, occasionally, nephrotoxic radio-opaque contrast medium. In this article the authors review the literature addressing the use of contrast-enhanced echocardiography (CEE) in ECMO-supported patients. The authors discuss the role of CEE in guiding implantation of ECMO, cardiac assessment and diagnosis of complications during ECMO therapy, as well as the safety of ultrasound-enhancing agents in this cohort of patients.

Keywords: ECMO; bicaval dual-lumen cannula; contrast-enhanced echocardiography; echocardiography.

Publication types

  • Review

MeSH terms

  • Echocardiography
  • Extracorporeal Membrane Oxygenation* / methods
  • Humans
  • Respiration, Artificial